Morgan Stanley sees writing on wall for key drug research stocks
Wall Street just split sharply on two stocks in the same industry. On Wednesday, June 17, Morgan Stanley upgraded Charles River Laboratories (CRL) to Overweight and downgraded IQVIA Holdings (IQV) to Equal-weight. The twist: IQVIA is buying lab assets that Charles River agreed to sell earlier this ...
The Source
THE STREET
Business
Walmart is selling a cooling blanket that’s ‘perfect for hot sleepers’ for 53% off
THE STREET·2h ago·3 min read
Business
IRS sounds alarm on major 401(k) mistakes you must avoid
THE STREET·2h ago·3 min read
Business
JPMorgan latest Broadcom outlook sends key signal
THE STREET·3h ago·3 min read
Business
Is Kroger open or closed for Juneteenth?
THE STREET·3h ago·3 min read
Related
On this beat
Business
Everyone Has Access to AI Now. Here’s What Will Actually Make Your Brand Stand Out.
ENTREPRENEUR·10h ago·3 min read
Business
What Building a Company Taught Me About Fatherhood
ENTREPRENEUR·10h ago·3 min read
Business
Xi wants China to boost demand. Why isn’t it working?
FT·53m ago·3 min read
Business
EU delays trade confrontation with China
FT·2h ago·3 min read